Further development of such peptide inhibitors toward a lead therapeutic candidate, if proven to be selective for the target and relatively free of clinical side effects, may eventually lead to novel treatments for neurodegenerative disorders ranging from Alzheimers disease to Frontotemporal dementia to Parkinsons disease, says Stuart Lipton, a professor of neuroscience at Scripps Research, who was not involved in the study
Some patients experience minimal digestive disruption, while others report significant gastrointestinal symptoms that may affect treatment adherence and quality of life
Your dose is in milli grams
Ultimately, then, orforglipron might suit those who want the most effective option for weight loss and blood sugar and are willing to accept stronger side effects
When you're ready to take the next step in your research, we're here to help you